
Feb 4, 2025, 17:18
Multimodal approaches combining IO and IO-based therapies for HCC – Digestive Cancers Europe
Digestive Cancers Europe shared a post on LinkedIn:
“Listen to COR2ED’s final episode of its four-part podcast series for healthcare professionals on hepatocellular carcinoma (HCC), “Intermediate HCC – the evolving role of immunotherapy (IO).”
This episode explores multimodal approaches that combine IO and IO-based therapies with locoregional treatments and highlights the essential role of a multidisciplinary care team.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 20:48
Apr 19, 2025, 20:25
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29
Apr 19, 2025, 17:53